Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Friggeri

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|September 5, 2019
Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize <i>A Priori</i> Pharmacokinetic/Pharmacodynamic Target Attainments in Individual PatientsClément Boidin, Laurent Bourguignon, Sabine Cohen, et al.
Anesthesia and Analgesia|April 8, 2021
Association Between Short-, Intermediate-, and Long-term Mortality and Myocardial Injury After Noncardiac Surgery After Hip Fracture Surgery: A Retrospective CohortCharles-Hervé Vacheron, Julie Hentzen, Mathieu Fauvernier, et al.
Infectious Diseases (London, England)|July 31, 2025
Comparison of antibiotic consumption and resistance in intensive care units in France before and during the COVID-19 pandemicAlain Lepape, Anais Machut, Christelle Elias, et al.
Antimicrobial Resistance and Infection Control|January 8, 2020
European intensive care physicians' experience of infections due to antibiotic-resistant bacteriaAlain Lepape, Astrid Jean, Jan De Waele, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumoniaClaire Roger, Bernard Allaouchiche, Daniel Quintão De Moraes, et al.
Journal of Leukocyte Biology|July 31, 2015
Marked alterations of neutrophil functions during sepsis-induced immunosuppressionJulie Demaret, Fabienne Venet, Arnaud Friggeri, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2015
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsisClaire Roger, Bastian Nucci, Benjamin Louart, et al.
Critical Care Medicine|October 26, 2023
Improved 30-Day Survival Estimation in ICU Patients: A Comparative Analysis of Different Approaches With Real-World DataCharles-Hervé Vacheron, Arnaud Friggeri, Chloe Gerbaud-Coulas, et al.
Journal of Critical Care|August 9, 2023
Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: A retrospective studyJean Bernard, Charles-Hervé Vacheron, Nicolas Vantard, et al.
The Journal of Hospital Infection|February 8, 2026
Carbapenem-resistant Acinetobacter baumannii infections in intensive care units: incidence, infection prevention and control and antimicrobial stewardship practices in the cross-border region between Italy and France, 2019-2022Costanza Vicentini, Roberta Bussolino, Elisabetta Kuczewski, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|September 5, 2019
Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize <i>A Priori</i> Pharmacokinetic/Pharmacodynamic Target Attainments in Individual PatientsClément Boidin, Laurent Bourguignon, Sabine Cohen, et al.
Anesthesia and Analgesia|April 8, 2021
Association Between Short-, Intermediate-, and Long-term Mortality and Myocardial Injury After Noncardiac Surgery After Hip Fracture Surgery: A Retrospective CohortCharles-Hervé Vacheron, Julie Hentzen, Mathieu Fauvernier, et al.
Infectious Diseases (London, England)|July 31, 2025
Comparison of antibiotic consumption and resistance in intensive care units in France before and during the COVID-19 pandemicAlain Lepape, Anais Machut, Christelle Elias, et al.
Antimicrobial Resistance and Infection Control|January 8, 2020
European intensive care physicians' experience of infections due to antibiotic-resistant bacteriaAlain Lepape, Astrid Jean, Jan De Waele, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumoniaClaire Roger, Bernard Allaouchiche, Daniel Quintão De Moraes, et al.
Journal of Leukocyte Biology|July 31, 2015
Marked alterations of neutrophil functions during sepsis-induced immunosuppressionJulie Demaret, Fabienne Venet, Arnaud Friggeri, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2015
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsisClaire Roger, Bastian Nucci, Benjamin Louart, et al.
Critical Care Medicine|October 26, 2023
Improved 30-Day Survival Estimation in ICU Patients: A Comparative Analysis of Different Approaches With Real-World DataCharles-Hervé Vacheron, Arnaud Friggeri, Chloe Gerbaud-Coulas, et al.
Journal of Critical Care|August 9, 2023
Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: A retrospective studyJean Bernard, Charles-Hervé Vacheron, Nicolas Vantard, et al.
The Journal of Hospital Infection|February 8, 2026
Carbapenem-resistant Acinetobacter baumannii infections in intensive care units: incidence, infection prevention and control and antimicrobial stewardship practices in the cross-border region between Italy and France, 2019-2022Costanza Vicentini, Roberta Bussolino, Elisabetta Kuczewski, et al.
Pageof 10